Cutting edge: An inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5058-5061

  Katoh, Shigeki ^a   Miyagi, Taeko ^b   Taniguchi, Haruko ^a   Matsubara, Yu Ichi ^c   Kadota, Jun Ichi ^c   Tominaga, Akira ^d   Kincade, Paul W ^e   Matsukura, Shigeru ^a   Kohno, Shigeru ^c  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Miyagi Cancer Center   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; LIPOPOLYSACCHARIDE; N ACETYLNEURAMINIC ACID DERIVATIVE; SIALIDASE;

ARTICLE; CELL SURFACE; ENZYME ACTIVITY; ENZYME INDUCTION; GLYCOSYLATION; HUMAN; HUMAN CELL; INCUBATION TIME; MOLECULAR RECOGNITION; MONOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; SIALYLATION;

ANTIGENS, CD44; AZIDES; BINDING SITES; CELL LINE; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITORS; GLYCOSYLATION; HUMANS; HYALURONIC ACID; LIPOPOLYSACCHARIDES; MONOCYTES; NEURAMINIDASE; SIALIC ACIDS;

EID: 0033136282     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Screaton, G. R., M. V. Bell, D. G. Jackson, F. B. Cornelis, U. Gerth, and J. I. Bell. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 89:12160.
2. Jalkanen, S., and M. Jalkanen. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:817.
3. Lesley, J., R. Hyman, and P. W. Kincade. 1993. CD44 and its interaction with the extracellular matrix. Adv. Immunol. 54:271.
4. Miyake, K., K. Medina, S.-I. Hayashi, S. Ono, T. Hamaoka, and P. W. Kincade. 1990. Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in longterm bone marrow cultures. J. Exp. Med. 171:477.
5. Jalkanen, S., M. Jalkanen, R. Bargatze, M. Tammi, and E.C. Butcher. 1988. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol. 141:1615.
6. Camp, R. L., A. Scheynius, C. Johansson, and E. Puré. 1993. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178:497.
7. DeGrendele, H. C., P., Estess, and M. H. Siegelman. 1997. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278:672.
8. Toyama-Sorimachi, N., F. Kitamura, H. Habuchi, Y. Tobita, K. Kimata, and M. Miyasaka. 1997. Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells. J. Biol. Chem. 272:26714.
9. Murakami, S., K. Miyake, C. H. June, P.W. Kincade, and R. J. Hodes. 1990. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 145: 3618.
10. Lesley, J., N. Howes, A. Perschl, and R. Hyman. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med 180:383.
11. Puré, E., R. L. Camp, D. Peritt, R. A. Panettieri, Jr., A. L. Lazaar, and S. Nayak. 1995. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181:55.
12. Lokeshwar, V. B., N. Fregien, and L. Y. W. Bourguignon. 1994. Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126:1099.
13. Kincade, P. W., Z. Zheng, S. Katoh, and L. Hanson. 1997. The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9:635.
14. Liu, D., and M.-S. Sy. 1997. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. J. Immunol. 159:2702.
15. Bennett, K. L., B. Modrell, B. Greenfield, A. Bartolazzi, I. Stamenkovic, R. Peach, D. G. Jackson, F. Spring, and A. Aruffo. 1995. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 131:1623.
16. Sleeman, J., W. Rudy, M. Hofmann, J. Moll, P. Herrlich, and H. Ponta. 1996. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol. 135:1139.
17. Katoh, S., Z. Zheng, K. Oritani, T. Shimozato, and P. W. Kincade. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182:419.
18. Lesley, J., N. English, A. Perchi, J. Gregoroff, and R. Hyman. 1995. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med 182:431.
19. Timothy, P. S., C. Zeng, A. Nocks, and I. Stamenkovic. 1998. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 140:431.
20. Webb, D. S. A., Y. Shimizu, G. A. V. Seventer, S. Shaw, and T. L. Gerrard. 1990. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 249:1295.
21. Noble, P. W., F. R. Lake, P. M. Henson, and D. W. H. Riches. 1993. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-α-dependent mechanism in murine macrophages. J. Clin. Invest. 91:2368.
22. Culty, M., T. E. O'Mara, C. B. Underhill, H. Yeager, Jr., and R. P. Swartz. 1994. Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages. J. Leukocyte Biol. 56:605.
23. Levesque, M. C., and B. F. Haynes. 1996. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulales monocyte variant CD44 isoform expression. J. Immunol. 156:1557.
24. Fujii, T., J.-I. Kadota, T. Morikawa, Y. Matsubara, K. Kawakami, K. Iida, R. Shirai, H. Taniguchi, M. Kaseda, S. Kawamoto, and S. Kohno. 1996. Inhibitory effect of erythromycin on interleukin 8 production by 1α, 25-dihydroxyvitamin D3-stimulated THP-1 cells. Antimicrob. Agents Chemother. 40:1548.
25. X as a new tumor-associated antigen. Cancer Res. 44:5279.
26. Miyagi, T., and S. Tsuiki. 1984. Rat-liver lysosomal sialidase: solubilization, substrate specificity and comparison with the cytosolic sialidase. Eur. J. Biochem. 141:75.
27. Miyagi, T., and S. Tsuiki. 1985. Purification and characterization of cytosolic sialidase from rat liver. J. Biol. Chem. 260:6710.
28. Miyagi, T., J. Sagawa, K. Konno, S. Handa, and S. Tsuiki. 1990. Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidase from the particulate fraction of rat brain. J. Biochem. 107:787.
29. Aminoff, D. 1961. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem. J. 81:384.
30. Guthridge, J. M., A. M. Kaplan, and D. A. Cohen. 1994. Regulation of B cell:T cell interactions: potential involvement of an endogenous B cell sialidase. Immunol. Invest. 23:393.
31. Zheng, Z., R. D. Cummings, P. E. Pummill, and P. W. Kincade. 1997. Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells. J. Clin. Invest. 100:1217.
32. Marc, C. L., and B. F. Haynes. 1997. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-α and is inhibited by IL-4 and IL-13. J. Immunol. 159:6184.
33. Landolfi, N. F., J. Leone, J. E. Womack, and R. G. Cook. 1985. Activation of T lymphocytes results in an increase in H-2-encoded neuraminidase. Immunogenetics 22:159.
34. Taira, S., and H. Nariuchi. 1988. Possible role of neuraminidase in activated T cells in the recognition of allogeneic Ia. J. Immunol. 141:440.
35. Bonten, E., A. van der Spoel, M. Fornerod, G. Grosveld, and A. d'Azzo. 1996. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Gene Dev. 10:3156.
36. Milner, C. M., S. V. Smith, M. B. Carrillo, G. L. Taylor, M. Hollinshead, and R. D. Campbell. 1997. Identification of a sialidase encoded in the human major histocompatibility complex. J. Biol. Chem. 272:4549.
37. Pshezhetsky, A. V., C. Richard, L. Michaud, S. Igdoura, S. Wang, M. Elsliger, J. Qu, D. Leclerc, R. Gravel, L. Dallaire, and M. Potier. 1997. Cloning expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat. Genet. 15:316.
38. Brown, M. S., R. G. W. Anderson, and J. L. Goldstein. 1983. Recycling receptors: the round trip itinerary of migrant membrane proteins. Cell 32:663.
39. Stahl, P., and A. L. Schwarz. 1986. Receptor mediated endocytosis. J. Clin. Invest. 77:657.
40. Bartolazzi, A., A. Nocks, A. Aruffo, F. Spring, and I. Stamenkovic. 1996. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell. Biol. 132:1199.
41. Zheng, Z., S. Katoh, Q. He, K. Oritani, K. Miyake, J. Lesley, R. Hyman, A. Hamik, R. M. E. Parkhouse, A. G. Fan, and P.W. Kincade. 1995. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell. Biol 130:485.